Improving Emergency Care and Outcomes of Immune-Related Adverse Events
Official Title
Improving emergency care and outcomes of immune-related adverse events: The immune related emergency disposition index (irEDI)
Purpose
The purpose of this study is to learn more about how to best care for patients who have immune-related side effects and have received treatment with an immune checkpoint inhibitor.
The duration of this study is 30 days.
Could this study be right for you?
- Must speak English and/or Spanish
- Diagnosis of cancer (excluding non-melanoma skin cancer)
- Last immunotherapy received within 90 days of study enrollment